SCHEMBL30547754

SCHEMBL30547754

O=C(O)c1cccc2c1cnn2CCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.43
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
ALDH1A1 P00352 2/20 0.37
POLB P06746 1/20 0.37
KDM4C Q9H3R0 2/20 0.36
HTR6 P50406 1/20 0.36
FSCN1 Q16658 1/20 0.36
KDM4A O75164 1/20 0.36
RAB9A P51151 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
HIF1AN Q9NWT6 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CNR2 P34972 1/20 0.35
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25966972 0.87 KDM4C (0.48) KMOKDM4EHSD17B10HPGDALDH1A1
SCHEMBL30622483 0.83 HPGD (0.41) KMOKDM4EHSD17B10HPGDNR4A1
SCHEMBL25969296 0.83 KDM4C (0.44) KMOKDM4EHSD17B10HPGDNR4A1
SCHEMBL30622472 0.83 POLB (0.41) KMOKDM4EHSD17B10HPGDALDH1A1
SCHEMBL15999099 0.83 SCN9A (0.49) KMOKDM4EHSD17B10HPGDNR4A1
SCHEMBL15999085 0.83 KDM4E (0.40) KMOKDM4EHSD17B10HPGDALDH1A1
SCHEMBL30622541 0.83 KDM4C (0.51) KMOKDM4EHSD17B10HPGDKDM4C
SCHEMBL15998983 0.81 RECQL (0.54) KDM4EHSD17B10HPGDALDH1A1KDM4C
SCHEMBL30622609 0.80 CNR1 (0.46) KDM4EALDH1A1KDM4CCNR2KMT2A
SCHEMBL15999091 0.79 KDM4E (0.39) KMOKDM4EHSD17B10HPGDNR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 KMO 2855/4885KDM4E 1156/4885HSD17B10 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.